BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8906288)

  • 1. Eosinophilia myalgia syndrome. The role of contaminants, the role of serotonergic metabolism set up.
    Nicolodi M; Sicuteri F
    Adv Exp Med Biol; 1996; 398():351-7. PubMed ID: 8906288
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of tryptophan related compounds on nuclear regulatory control. Possible role in the eosinophilia-myalgia syndrome.
    Sidransky H; Verney E; Latham P; Schwartz A
    Adv Exp Med Biol; 1996; 398():343-50. PubMed ID: 8906287
    [No Abstract]   [Full Text] [Related]  

  • 3. [5-Hydroxytryptamine and physiopathology of pain; on a polyalgic syndrome in the course of therapy with para-chlorophenylalanine].
    Sicuteri F; Anselmi B; Franchi G; Fanciullacci M; Del Bianco PL
    Clin Ter; 1972 Jun; 61(6):491-501. PubMed ID: 4273807
    [No Abstract]   [Full Text] [Related]  

  • 4. L-tryptophan-induced eosinophilia-myalgia syndrome. II. Partial correction of abnormal tryptophan metabolism by pyridoxine.
    Mainetti C; Fathi M; Saurat JH
    Dermatologica; 1991; 183(1):62-5. PubMed ID: 1722762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myalgia-eosinophilia syndrome. Tryptophan disease].
    Cabane J
    Rev Prat; 1991 Dec; 41(25):2583-7. PubMed ID: 1803472
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there any relationship between eosinophilia myalgia syndrome (EMS) and fibromyalgia syndrome (FMS)? An analysis of clinical and immunological data.
    Barth H; Berg PA; Klein R
    Adv Exp Med Biol; 1999; 467():487-96. PubMed ID: 10721092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A heretofore undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation.
    Smith MJ; Garrett RH
    Inflamm Res; 2005 Nov; 54(11):435-50. PubMed ID: 16307217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The eosinophilia-myalgia syndrome--guidelines for patient care.
    Hertzman PA; Kaufman LD; Love LA; Mease PJ; Philen RM; Pincus T; Rosenberg NL; Silver R; Varga J; Clauw DJ
    J Rheumatol; 1995 Jan; 22(1):161-3. PubMed ID: 7699664
    [No Abstract]   [Full Text] [Related]  

  • 9. Eosinophilia-myalgia syndrome: description of an unusual case.
    Giordano N; Senesi M; Monaco R; Palumbo F; Battisti E; Nardi P; Mattii G; Gennari C
    Clin Exp Rheumatol; 1997; 15(2):222-3. PubMed ID: 9196880
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevated L-kynurenine level and its normalization by prednisolone in a patient with eosinophilia-myalgia syndrome.
    Hisatomi A; Kubota A; Ohashi M; Umeda F; Nawata H; Imamura T; Nagata T
    Fukuoka Igaku Zasshi; 1997 Jan; 88(1):11-7. PubMed ID: 9037890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parachlorophenylalanine, an inhibitor of enteramine (serotonin) synthesis in migraine.
    Sicuteri F; Anselmi B; Fanciullacci M
    Res Clin Stud Headache; 1970; 3():310-4. PubMed ID: 4266611
    [No Abstract]   [Full Text] [Related]  

  • 12. [Migraine, serotonin and serotonergic receptors].
    Pascual J
    Neurologia; 1993; 8(6):180-3. PubMed ID: 8394726
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhanced collagen synthesis and transcription by peak E, a contaminant of L-tryptophan preparations associated with the eosinophilia myalgia syndrome epidemic.
    Takagi H; Ochoa MS; Zhou L; Helfman T; Murata H; Falanga V
    J Clin Invest; 1995 Nov; 96(5):2120-5. PubMed ID: 7593596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset.
    Hertzman PA; Clauw DJ; Kaufman LD; Varga J; Silver RM; Thacker HL; Mease P; Espinoza LR; Pincus T
    Ann Intern Med; 1995 Jun; 122(11):851-5. PubMed ID: 7741371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper extremity contractures in a patient with eosinophilia-myalgia syndrome.
    Marchman HB; Gleason CB; Shaw JC
    Arch Phys Med Rehabil; 1991 Nov; 72(12):1029-30. PubMed ID: 1953317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilia-myalgia syndrome or fibromyalgia with eosinophilia?
    Hudson JI; Pope HG; Daniels SR; Horwitz RI
    JAMA; 1993 Jun 23-30; 269(24):3108-9. PubMed ID: 8505810
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormalities of the coronary arteries, neural structures and conduction system of the heart observed postmortem in the eosinophilia-myalgia syndrome, with a discussion of comparative findings from the toxic oil syndrome.
    James TN
    Trans Am Clin Climatol Assoc; 1991; 102():52-81; discussion 81-3. PubMed ID: 2130570
    [No Abstract]   [Full Text] [Related]  

  • 18. A contaminant of L-tryptophan enhances expression of dermal collagen in a murine model of eosinophilia myalgia syndrome.
    Suzuki S; Tourkina E; Ludwicka A; Hampton M; Bolster M; Maize J; Silver R
    Proc Assoc Am Physicians; 1996 Jul; 108(4):315-22. PubMed ID: 8863345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of serotonin and serotonin receptors in the pathogenesis of migraine and in the mechanisms of action of anti-migraine drugs].
    Amelin AV; Skoromets AA; Ignatov IuD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(7):55-8. PubMed ID: 10957805
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of serotonin metabolism in migraine.
    Anthony M; Hinterberger H; Lance JW
    Proc Aust Assoc Neurol; 1968; 5(1):109-12. PubMed ID: 5709949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.